AU2001278714A1 - Vascular relaxation agents - Google Patents

Vascular relaxation agents

Info

Publication number
AU2001278714A1
AU2001278714A1 AU2001278714A AU7871401A AU2001278714A1 AU 2001278714 A1 AU2001278714 A1 AU 2001278714A1 AU 2001278714 A AU2001278714 A AU 2001278714A AU 7871401 A AU7871401 A AU 7871401A AU 2001278714 A1 AU2001278714 A1 AU 2001278714A1
Authority
AU
Australia
Prior art keywords
vascular relaxation
relaxation agents
agents
vascular
relaxation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278714A
Inventor
Toshio Ohhashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU2001278714A1 publication Critical patent/AU2001278714A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AU2001278714A 2000-08-11 2001-08-10 Vascular relaxation agents Abandoned AU2001278714A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-243873 2000-08-11
JP2000243873 2000-08-11
PCT/JP2001/006943 WO2002013852A1 (en) 2000-08-11 2001-08-10 Vascular relaxation agents

Publications (1)

Publication Number Publication Date
AU2001278714A1 true AU2001278714A1 (en) 2002-02-25

Family

ID=18734659

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278714A Abandoned AU2001278714A1 (en) 2000-08-11 2001-08-10 Vascular relaxation agents

Country Status (4)

Country Link
US (1) US20030181373A1 (en)
EP (1) EP1312376A1 (en)
AU (1) AU2001278714A1 (en)
WO (1) WO2002013852A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005107461A2 (en) * 2004-04-07 2005-11-17 The General Hospital Corporation Modulating lymphatic function
US8455435B2 (en) * 2006-04-19 2013-06-04 Ludwig-Maximilians-Universitat Munchen Remedies for ischemia
EP2007416B1 (en) * 2006-04-19 2017-09-27 Ludwig-Maximilians-Universität München Paratyroid hormone (pth) for use in the treatment of ischemia
CN103018430B (en) * 2012-11-22 2014-07-02 上海交通大学医学院附属仁济医院 Serially-connected blood vessel grooves for blood vessel perfusion system
CN109580702B (en) * 2018-11-26 2020-10-16 中国石油大学(北京) Method for measuring uniform temperature and freezing point temperature of fluid inclusion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4771124A (en) * 1987-05-26 1988-09-13 Merck & Co., Inc. Parathyroid hormone antagonists with simplified synthetic methodology
US5001223A (en) * 1987-05-26 1991-03-19 Merck & Co., Inc. Parathyroid hormone antagonists with enhanced metabolic properties
US4927629A (en) * 1987-12-17 1990-05-22 Huntington Medical Research Institutes Relaxation of smooth vascular muscle
US5217896A (en) * 1988-12-30 1993-06-08 Oncogene Science, Inc. Monoclonal antibodies recognizing parathyroid hormone-like protein
US5849695A (en) * 1993-01-13 1998-12-15 The Regents Of The University Of California Parathyroid hormone analogues useful for treatment of osteoporosis and disorders of calcium meatabolism in mammals
US5993817A (en) * 1995-01-23 1999-11-30 Xenotech Method to ameliorate osteolysis and metastasis
US5626845A (en) * 1995-01-23 1997-05-06 Xenotech Incorporated Method to ameliorate osteolysis and metastasis

Also Published As

Publication number Publication date
WO2002013852A1 (en) 2002-02-21
EP1312376A1 (en) 2003-05-21
US20030181373A1 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
AU2001252135A1 (en) Therapeutic agents
AU2001288720A1 (en) Implantable article
AU2002213152A1 (en) Mri stent
AU2001260327A1 (en) Chair
AU2002257241A1 (en) Vascular needle
AU2001288040A1 (en) Homeostasis-maintaining agents
AU2002214284A1 (en) Anti-helicobacterial agents
GB0009591D0 (en) Medical combinations
AU4647601A (en) Vascular device
AU2001280598A1 (en) Anti-occlusion catheter
AU2001276146A1 (en) Vascular anchoring device
AU2001259702A1 (en) Tissue regrafting
IL149215A0 (en) Shelving
AU2002227925A1 (en) Human beta-defensin-3
AU2001273903A1 (en) Therapeutic agents
AU2001278714A1 (en) Vascular relaxation agents
AU2001252200A1 (en) Chair
AU2001266140A1 (en) Baths
AU2001275696A1 (en) Therapeutic agent
AUPR024300A0 (en) Tissue bonding agent
AUPR069500A0 (en) Tissue modification
AU2001275764A1 (en) Skin lightening agents
AU2001274683A1 (en) Contrast agents
GB2370013B (en) Furniture
AU2002215030A1 (en) Chair